Von Willebrand factor in the outcome of temporal arteritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 12, 1996, Pages 927-930

  Cid, Maria C ^a   Monteagudo, Joan ^a   Oristrell, Joaquim ^c   Vilaseca, Jaume ^b   Pallarés, Lucio ^a   Cervera, Ricard ^a   Font, Carme ^a   Font, Josep ^a   Ingelmo, Miguel ^a   Urbano Márquez, Alvaro ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Consorci Hospitalari del Parc Tauli ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS;

EID: 8044220288     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.12.927     Document Type: Article

References (15)

1. Blann AD. Von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J Rheumatol 1993;20:1469-71.
2. Sixma JJ, de Groot PG. Von Willebrand factor and the blood vessel wall. Mayo Clin Proc 1991;66:628-33.
3. Nusinow SR, Federici AB, Zimmerman TS, Curd JG. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984;27:1405-10.
4. Woolf AD, Wakerley G, Wallington TB, Scott DGI, Dieppe PA. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987;46:441-7.
5. Federici AB, Fox RI, Espinoza LR, Zimmerman TS. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Arthritis Rheum 1984; 27:1046-9.
6. Persellin ST, Daniels TM, Rings LJ, Kazmier FJ, Bowie EJM, Hunder GG. Factor VIII-von Willebrand factor in giant-cell arteritis and polymyalgia rheumatica. Mayo Clin Proc 1985;60:457-62.
7. Olsson A, Elling P, Elling H. Serological and immunohistochemical determination of von Willebrand factor antigen in serum, and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica. Clin Exp Rheumatol 1990;8:55-8.
8. Nordborg E, Andersson R, Tengborn L, Eden S, Bengtsson BA. von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis. Ann Rheum Dis 1991;50:316-20.
9. Monteagudo J, Pereira A, Roig S, Reverter JC, Ordinas A, Castillo R. Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome. Am J Hematol 1990;33:46-9.
10. Mazzone D, Fichera A, Practico G, Sciacia F. Factor VIII activity and factor VIII-related antigen in infants with viral bronchiolitis. N Engl J Med 1984;311:1257-8.
11. Paleolog EM, Crossman DC, McVey JH, Pearson JD. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 1990;75:688-95.
12. Cid MC, Campo E, Ercilla MG, Palacín A, Vilaseca J, Villalta J, et al. Immunohistochemical analysis of lymphoid and macrophage cell subset and their immunological activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum 1989;32:884-93.
13. Fauchald P, Rygvold O, Oytesse B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972;77:845-52.
14. Cid MC, DS Grant, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-85.
15. Reidy MA, Chopek M, Chao S, McDonald T, Schwartz SM. Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol 1989;134:857-64.